GH1 and fatty liver disease: However, increasing evidence is showing the association of low circulating GH levels [177] and IGF1 levels [178,179,180] with hepatic steatosis, and inactivating mutations in the GHR [181] of mice resulted in hepatic steatosis due to enhanced lipogenesis and reduced TG secretion from the liver [182].